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Abstract. The misfolding and self-assembly of intrinsically disordered proteins into insoluble amyloid structures
are central to many neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases. Optical imaging
of this self-assembly process in vitro and in cells is revolutionizing our understanding of the molecular mech-
anisms behind these devastating conditions. In contrast to conventional biophysical methods, optical imaging
and, in particular, optical superresolution imaging, permits the dynamic investigation of the molecular self-
assembly process in vitro and in cells, at molecular-level resolution. In this article, current state-of-the-art imaging
methods are reviewed and discussed in the context of research into neurodegeneration. © The Authors. Published by
SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of
the original publication, including its DOI. [DOI: 10.1117/1.NPh.3.4.041807]
Keywords: Alzheimer’s disease; protein misfolding; superresolution microscopy; protein aggregation.
Paper 16016SSR received Mar. 17, 2016; accepted for publication Jun. 13, 2016; published online Jun. 29, 2016.
1 Introduction
Proteins have an intrinsic propensity to self-assemble into
aggregates. The process is initiated by the formation of an
aggregation-nucleus from the native monomers; this is a small
oligomeric species consisting of only a few monomer units,
from which aggregation then proceeds via association of further
monomers. Kinetically, the nucleus is a unit for which the rate of
further monomer association is larger than that of dissociation.
Such oligomers are called “on-pathway” species, because their
presence increases the propensity of the protein pool to aggre-
gate. In contrast, oligomers that block the growth of aggregates
are called “off-pathway” species; these can dissociate and act as
a source for monomers.1 Usually, aggregation corresponds to the
association of proteins, whose polypeptide chain is folded into
a nonfunctional structural state; one says the protein is in
a “misfolded state.” Aggregation thus propagates the misfolded
protein state and this phenomenon is at the heart of a number of
so-called “protein misfolding diseases.”2,3 A key problem in
misfolding diseases is that normal protein homeostasis is dis-
rupted in the cell, as aggregation lowers the propensity of
the protein pool to remain soluble. Small oligomeric species
may furthermore elicit toxicity directly through interference
with vital metabolic processes in the cell. These problems are
at the heart of major neurodegenerative diseases, such as
Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), in
which usually harmless, soluble proteins self-assemble into
highly regular, fibrillar aggregate structures called amyloids,4
which may elicit structure-specific phenotypes. In AD and
PD, amyloids are formed from intrinsically disordered proteins
(IDPs), i.e., those that normally lack defined secondary and
tertiary structures under physiological conditions. In response
to changes in the molecular environment or due to point
mutations in their peptide sequence, IDPs partially fold and
adopt metastable β-sheet conformations (see Fig. 1). These par-
tially folded states self-assemble into oligomers, which then
gradually convert into stable, β-sheet rich conformations, thus
forming aggregation nuclei, from which elongation into the
fibrillar amyloid state then proceeds through consecutive
monomer addition.5 In both AD and PD, aggregation appears
to be initiated in certain, well-defined regions in the brain,
before the gradual spreading of aggregated species takes place
throughout the entire brain. In the final stages of the disease, a
significant fraction of the brain mass of affected patients is
replaced by insoluble solid plaques, which are predominantly
composed of fibrillar amyloids of the proteins tau and amyloid
β (Aβ) in Alzheimer’s, and the protein α-synuclein in the case
of PD.
The environmental conditions that favor, or hamper, the self-
assembly of proteins into amyloid fibrils, the propagation of
misfolded species from cell to cell, the effect of point mutations
on the aggregation process, the possible interaction with, and
inhibition of, amyloid aggregation via small molecule drugs,
the structural identification and physiological interaction of
toxic species in brain cells, and so on are all questions at the
heart of a better understanding of these devastating diseases
and the focus of much ongoing biophysical research. Optical
techniques play a crucial role in this effort, because of their non-
intrusive nature, their suitability to track the kinetics of the self-
assembly process in time and their high sensitivity and specific-
ity in combination with fluorescent labeling techniques, which
makes them suitable for applications in cells and even in vivo. In
what follows, we review techniques pioneered in our laboratory
and by others, for studies of amyloid formation optically, with
nanoscale resolution. We begin with indirect methods, which we
term “multiparameter imaging,” where molecular-level informa-
tion is conveyed via changes in spectral properties of reporter
fluorophores, e.g., changes in the fluorescence lifetime, or
the polarization of emitted radiation. Bulk measurements with
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multiparameter methods are presented first, before applications
are discussed in combination with microscopic imaging. We
then review the application of single-molecule superresolution
microscopy, which reveals morphological information of single
aggregate clusters at the molecular scale.
2 Bulk Measurements to Study Fibril Growth
Traditional optical techniques well suited for bulk measure-
ments include the use of far UV circular dichroism and
Fourier transform infrared spectroscopy, which inform on
the content of β-sheet to α-helical structure in unlabeled
Fig. 1 Simplified pathway toward amyloid fibril formation. In the misfolded-state proteins have an
increased propensity to oligomerize, via association of their metastable beta-sheet domains. These
can convert into more stable beta-sheet states and the ensuing oligomers act as the nuclei for the sub-
sequent elongation reaction, which leads to the formation of so-called protofibrils. The final amyloid
fibril usually consists of a number or intertwined protofibrils.
Fig. 2 Intrinsic fluorescence informs on amyloid growth kinetics without the requirement for any extrinsic
fluorescence labels. (a) Short, fibrillar seeds of α-synuclein, shown in blue, serve as the template from
which fibril elongation proceeds through addition of monomers, shown in red. The top panel to the right
shows atomic force microscopy (AFM) images of short fibril seeds at the start of the reaction, at t ¼ 0.
Below is an image of the same sample at t ¼ 5 h. Clearly, the elongation of the seeds into long amyloid
fibrils has taken place. (b) Structural model of amyloid fibril, consisting of intertwined protofibrils.
(c) Zoomed-in region indicated in b that shows the atomic arrangement between adjacent N- and C-ter-
mini from intertwined protofibrils. (d) Rise in intrinsic fluorescence from the amyloid fibrils in time. The blue
points correspond to the elongation of α-synuclein seeds in the presence of α-synuclein monomer. The
black points correspond to the addition of β-synuclein monomers to the α-synclein seed fibrils and confirm
that the two species cannot “cross-seed” aggregation. The fluorescence measurements were performed
with a diode laser emitting near 405 nm and signals were detected around 450 nm. Similar spectral
characteristics were observed for hen egg white lysozyme,11 tau,12 and various mutants of amyloid
beta.13 Figure reprinted with permission from Ref. 12, copyright 2014 Wiley [panels (a) and (d)] and
Ref. 13, copyright 2016 American Chemical Society [panels (b) and (c)].
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proteins.6,7 Furthermore, small molecule dyes, such as thioflavin
T (ThT), that bind with a high propensity to the β-sheet rich
fibrillar state of amyloids can be used to track the aggregation
state in bulk.8 The rise in ThT fluorescence emission in mixtures
containing aggregating peptides is a popular method to track the
kinetics of amyloid formation in vitro.9 Although the exact
mechanisms by which ThT fluorescence is affected by fibril
binding is still incompletely understood, it is thought that inter-
calation of the dye in the fibril grooves leads to a stabilization of
the molecule in a configuration, which enhances electron delo-
calization and thus transition dipole moments.
An intriguing phenomenon recently discovered is that the
formation of amyloid fibrils is accompanied by the adoption
of a structure-specific intrinsic fluorescence in the visible range,
independent of the presence of aromatic residues in the polypep-
tide chain.10,11 This provides for a tool in the diagnostics of
aggregation kinetics in vitro and has been used as a quantitative
assay, e.g., to study the elongation reactions of α-synuclein,12
see Figs. 2(a), 2(b), and 2(d). This study focused on the elon-
gation of fibrillar template species in the presence of monomers
of α-synuclein, and clearly exponential growth of fibrils is evi-
dent as a function of incubation time. Growth rates recede
gradually, as the monomer concentration becomes depleted dur-
ing fibril growth.
Fluorescence was furthermore confirmed to be independent
of the presence of aromatic side chains in the studied proteins
and to occur in a wavelength range far removed spectrally from
that of traditional intrinsic protein fluorescence (excitation near
400 nm, emission >450-nm emission range).12 The intrinsic
fluorescence properties were found to be similar for many differ-
ent amyloids tested and strong enough to render fibrils visible
under the microscope. For example, absorption and emission
spectra of the amyloid proteins tau, lysozyme, and amyloid
beta were shown to exhibit very similar features to those of
α-synuclein, as reported in Refs. 10, 11, and 13, respectively.
We have recently confirmed via ab initio molecular dynam-
ics, and simulations that protons situated along H-bonds involv-
ing N─C termini between adjacent fibril strands can be
exceptionally labile. This leads to situations in which the proton
can hop between the N- and C-termini of adjacent strands, a
situation that is exacerbated via nuclear quantum effects. The
result is a strong delocalization of protons along the H-bond
co-ordinate axis, which in turn imparts a very significant effect
on the optical properties of amyloid systems and likely also
their physicochemical properties.13
While a useful tool for kinetic studies of purified protein
in vitro, the intrinsic fluorescence is too unspecific and weak
to be useful in more complex assays, e.g., for high-resolution
Fig. 3 Imaging the aggregation state of α-synuclein in a live C. elegans model of α-synuclein aggrega-
tion. (a) Example images of protein expressed in neuronal cells in the live worms. The panel on the left
shows a bright-field image of the nematode, on which the fluorescence image of the labeled amyloid is
superimposed in green. The right panel shows the corresponding fluorescence lifetimes determined by
TCSPC confocal microscopy. (b) Fluorescence lifetime as a function of age for live worm expressing
different protein constructs. Black bars indicate α-synuclein-YFP; white bars indicate YFP controls;
and gray bars indicate Q40-YFP worms. Clearly, a monotonic decrease in the lifetime is observed
with age for the worms expressing α-synuclein-YFP, indicating increasing progress of aggregation.
The observed drop in lifetime has been explained in terms of nonresonant energy transfer processes
to absorbing states in the emerging amyloid scaffold,24 but recent work suggests that fluorescence
self-quenching also plays an important role in this process.25 The monotonous decrease of the observed
lifetimes reflect a mixture of low lifetimes of increasingly aggregated protein that emerges in the aging
worm and larger lifetimes of newly synthesized protein that is continuously produced in the nematode.
For the strongly aggregating Q40-YFP, the corresponding drop in lifetime is even more rapid than for
α-synuclein. (c) Increasing aggregation of α-synculein leads to an emerging toxic phenotype: From day 8,
worms exhibit increasing loss of movement, concurrent with the appearance of small toxic oligomers as
verified by TCSPC imaging. Figure reprint with permission from Ref. 24, copyright 2011 Wiley.
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microscopy techniques or for studies in cells or organisms.
Specificity and sensitivity can be conferred via fluorescent
labels that are covalently linked to the protein of interest.
Labeling of primary amine groups is possible via succinimidyl
esters, but control over the binding site can be difficult, causing
possible interference with the amyloid self-assembly process.14
Site-specific labeling is possible via maleimide dyes, which
react only with cysteine residues. Specific cysteine residues
can be replaced or introduced through site selective mutagene-
sis; this allows the covalent and specific labeling of domains,
which lie outside of the amyloid specific misfolding region,
thus minimizing the risk of steric interference with the aggrega-
tion process.15 For superresolution microscopy in particular,
this permits the introduction of highly efficient organic dyes,
optimally suited to the imaging task at hand.
In all cases, the propensity of the protein to aggregate with
comparable behavior to the wild-type protein and to form fibrils
featuring similar morphologies, needs to be carefully checked
using biophysical assays, such as nuclear magnetic resonance,
AFM, and scanning electron microscopy (SEM). This is particu-
larly true for the use of fusion proteins as labels, whose size can
exceed that of labeled peptide. Nevertheless, the use of variants
Fig. 4 α-synuclein elongation assay performed with dSTORM superresolution microscopy. The assay
corresponds to the same conditions as for the bulk measurements shown in Fig. 2. Small fibril seed
species, shown in green, are incubated in solution containing monomeric α-synuclein, shown in red.
α-synuclein seeds were covalently labeled with Alexa Fluor® 568 and monomer with Alexa Fluor®
647 dyes, respectively. The images show the time-sequenced growth of individual α-synuclein fibrils.
(a–h) Clearly, growth takes place from both ends of the seed fibril, extending to several micrometers
in length after 24 h. The last image (i) shows a conventional fluorescence microscopy image, blurred
by optical diffraction. Adapted with permission from Ref. 32, copyright 2014 American Chemical Society.
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of green fluorescent protein has been demonstrated successfully
for a range of amyloid peptides, yielding similar aggregation
kinetics and fibril morphology as the wild-type protein.16
3 Functional Imaging of Amyloid Growth
Kinetics
Fusion protein technology permits imaging directly at the live
cell, or even organism, level.17,18 This opens a whole range of
possibilities for functional imaging techniques, so-called multi-
parameter imaging techniques, that report on molecular self-
assembly directly in aggregation models of patho-biological rel-
evance. The use of homoFRET reports on aggregation via an
increasing loss of fluorescence polarization in growing aggre-
gates, upon excitation with polarized laser light.19 It was pos-
sible with this technique to image with high sensitivity the
formation of aggregates in an α-synuclein-YFP model of aggre-
gation using a confocal microscopy setup with polarization-
resolved fluorescence detection.16 The fluorescence lifetime is
also a sensitive reporter on the local environment of a
fluorophore.20 For example, it was shown that the fluorescence
lifetime from appropriate fluorophore labels covalently attached
to environmentally responsive polymers informs on the folding
kinetics of the latter in live cells.21,22 Notably, it was recently
discovered that aggregation into β-sheet-rich amyloid fibrils
is similarly accompanied by dramatic changes in the fluores-
cence lifetime. However, here the mechanism differs, and the
phenomenon appears to be caused by energy transfer as the mol-
ecules become more highly confined in the aggregating protein
structures; as a result, the fluorescence lifetime of appropriately
selected reporter fluorophores decreases upon fibril formation
and this can be used as an in vivo tool to track the aggregation
kinetics with microscopy.23 We have used this technique to
report, for the first time, on the aggregation of α-synuclein in
a live Caenorhabditis elegans (C. elegans) model of protein
aggregation, see Fig. 3, and were able to correlate the appear-
ance of aggregate species with the emergence of a toxic
phenotype.24 Similarly, in a recent study, we have used this tech-
nique to track the structural “fate” of amyloid-beta protein
ingested in neuronal cell lines and found that the compartmen-
talization ofAβ into small acidic vesicles induces aggregation of
the protein, a finding that is significant in context of the disease,
providing potential targets for therapeutic strategies.26
4 Optical Superresolution Imaging of
Amyloid Formation
While multiparameter optical microscopy offers powerful
glimpses into the kinetics of aggregation, its optical resolution
is limited by diffraction, and it is thus not capable of offering
Fig. 5 AD CSF reveals limited seeding activity in a single-molecule resolution assay in vitro compared to
brain tissue. (a–d) Representative superresolved (a, and c) and diffraction-limited fluorescence (b, and d)
images of HF647-labeled amyloid-β1-40 peptide fibrils that were seeded for 72 h with the soluble AD
brain fraction (a and b) and AD CSF (c, and d). Scale bar: 2 μm. (E and F) Higher magnification
(four examples) of superresolution images of soluble AD brain fraction-induced aggregates (e) and
the AD CSF-induced aggregates (f) (in green, antibody CN3 against human amyloid-β peptide; in
red, HF647-labeled amyloid-β1-40 peptide). Scale bar: 1 μm. (g) Measurement of the amyloid-β-immuno-
positive particles (labeled green in e and f) revealed smaller amyloid-β-positive particles in the CSF com-
pared to the amyloid-β-positive particles in the supernatant (SN) fraction. CN3 does not easily recognize
the elongated HF647-labeled amyloid-β1-40 peptide, presumably because of steric hindrance. (h) Mean
size of the amyloid-β-labeled and elongated particles (labeled red in e and f). As a control, amyloid-β1-40
peptide only was used and this measurement was taken as baseline. Consistent with the images shown
in a–d, the SN-induced amyloid-β aggregates were at least threefold larger compared to the CSF-induced
amyloid-β aggregates. Five to six randomly chosen areas (as shown in a–d) were analyzed per sample:
two SN fractions, and two AD CSF specimens were analyzed. Adapted with permission from Ref. 35,
copyright 2014 Oxford University Press.
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morphological information on the formed species, or to verify
the colocalization with subcellular targets, e.g., vesicles or mito-
chondria, with good enough spatial resolution. The advent of
optical superresolution microscopy techniques has led to a para-
digm shift in this field. The first application of single-molecule
superresolution imaging techniques for the visualization of
amyloids was by Duim et al,27 where blink microscopy was used
to record fibrils of polyQ protein, a model for Huntington’s
disease. Using the technique of direct stochastic optical
reconstruction microscopy (dSTORM),28 we were able to
image in vitro and in cells the morphology of Aβ fibrils with
a resolution better than 20 nm.29 The latter study highlighted
the influence of the cellular environment on aggregation kinetics
and species morphology, differing markedly to what was
observed for comparable conditions in vitro, in the test tube.
In contrast, fibrillar polyQ species appeared to be more similar
between the corresponding in vitro and in cellulo cases, as
observed in the study by Sahl et al.30 Similarly, the aggregation
of human lysozyme, which occurs in a certain case of hereditary
amyloidosis linked to specific lysozyme mutations, was
observed both in vitro and in cells using dSTORM and showed
similar morphological features.31 In general, such insights are
offered now by superresolution imaging methods as their spatial
resolution approaches that of AFM or SEM techniques, while
offering the advantages of specificity and sensitivity that
come with all-optical techniques. In Fig. 4, we show how
dSTORM permits the tracking of fibril growth at the single-
molecule level, offering information on the self-assembly proc-
ess, which is not accessible from bulk measurements.32 The
images correspond to the “seeded growth” assay of α-synuclein
as discussed in Sec. 2, for which bulk fluorescence data are
shown in Fig. 2.
Clearly, growth is seen for individual molecular species.
Several insights were obtained from this study that could not
have been verified otherwise. First, fibril growth clearly pro-
ceeds from both ends of the fibril seeds, a hypothesis, that
had been the subject of considerable debate for lack of conclu-
sive evidence. Second, it was possible to show that the growth
rates of individual fibrils varied by orders of magnitude; while
some fibrils grew hardly at all, others elongated extensively over
the same aggregation period.32 The experiment dismissed both
random diffusion or the so-called “stop-and-go”’ models of
monomer addition, and instead points to the likely existence of
several “misfolding states,” for which aggregation can proceed,
Fig. 6 Uptake of monomeric tau protein into neuron-like cells causes its aggregation and subsequent
recruitment of endogenous tau, normally present in the cell. (a i) Lifetime image of K18Tau, covalently
labeled with Alexa Fluor® 488 fluorophore, which does not aggregate in the extracellular space. (a ii)
Confocal fluorescence intensity image displaying the distribution of K18Tau inside the cell upon inges-
tion. Independent experiments confirm compartmentalization in acidic, endocytotic vesicles (not shown).
(a iii) TCSPC-fluorescence lifetime images of the ingested protein suggests that significant aggregation
has taken place upon protein ingestion. Compared to the incubating solution, shown in a i, the vesicular
species show significantly reduced lifetimes, a iii, down by ca. 500 ps. (b) In vitro confirmation by TCSPC
to show that low pH leads to aggregation of monomeric tau. (b i) K18Tau at pH 7.4 and (b ii) tau aggregate
forming at pH 4.7. (c) Average fluorescent lifetimes of monomers and aggregates shown in b.
(d) Incubation of cells with K18Tau leads to the release of fibrillar aggregates, containing both endog-
enous, intracellular tau, green, coaggregating with the extracellular K18Tau, which was ingested by the
cell, shown in red. The two-color dSTORM superresolution experiment confirms a prion-like propagation
of misfolded tau species in this cell model, which may be highly relevant to the human form of AD. This
figure was originally published in Ref. 36, © the American Society for Biochemistry and Molecular
Biology, reproduced here with permission.
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but which feature individually differing growth rates. It is pos-
sible then with such techniques to verify, even in cells,33 whether
certain mutants of amyloids “cross-seed” other species, e.g.,
whether certain toxic species can “force” healthy species to
coaggregate. The latter is a variant of the “prion-like propaga-
tion”model of amyloid spreading in disease, recently confirmed
for α-synuclein in neurons.34
This idea was explored for amyloid beta, the protein at the
heart of AD, in Ref. 35. In this study, soluble brain and cerbro-
spinal fluid (CSF) samples from patients with AD were diluted
and injected into the hippocampal tissue of young, amyloid pre-
cursor protein transgenic mice. When brain tissue from mice
thus treated was analyzed 8 months later, it was shown,
using superresolution imaging and other techniques, that the
capacity to seed the aggregation process is much higher for
brain tissue than for CSF, even when the former is massively
diluted compared to the latter. An example of a relevant super-
resolution experiment, performed in vitro, is shown in Fig. 5.
Here, extracts from brain samples [Figs. 5(a) and 5(b)] and
CSF [Figs. 5(c) and 5(d)] from Alzheimer patients were fluores-
cently labeled (red) and incubated with differentially labeled
monomer (green) in vitro and the aggregation of the latter
tracked in time [Figs. 5(e) and 5(f)]. The capacity of brain sam-
ples to seed monomer aggregation was found to be much
enhanced over that of CSF-induced aggregation.
In another study led by Michel et al,36 we used both multi-
parameter and superresolution imaging to verify how the protein
tau propagates in a cell model of tau aggregation. In this study,
a short fragment of the human form of the protein tau, K18Tau,
covalently labeled with a synthetic fluorophore, was used as a
monomeric solution to incubate neuron-like cells (see Fig. 6).
Confocal time-correlated single photon counting (TCSPC)
microscopy reveals that the protein is readily taken up by
cells and is compartmentalized in endocytotic vesicles, small
acidic compartments that quite apparently enhance the aggrega-
tion rate of the ingested protein. The fluorescence lifetime of
the reporter fluorophore drops dramatically upon ingestion
into the cells indicating a strong degree of tau aggregation is
taking place. This led to the proposal that acidic conditions
favor tau aggregation, which was verified in vitro, again via mul-
tiparametric imaging (see panels b and c in Fig. 6). Indeed, this
finding suggests that uptake of tau via endocytosis is potentially
Fig. 7 TIRF-SIM is capable of simultaneous imaging in multiple colors with sub-100-nm resolution.
Panels (a) and (b) demonstrate the resolution enhancement of the method on 100-nm beads labeled
with multiple colors and excited at 488 and 640 nm wavelength illumination, respectively. The images
are divided across the diagonal to show the improvement obtained in going from wide-field imaging (top
left part) to TIRF-SIM (bottom right part). (c) A full width at half maximum fit to bead cross sections for a
population of beads demonstrating the excellent resolution achievable with the method, and (d) beta
amyloid fibrils labeled with 10% rhodamine derivative (488-nm resolution). Scale bars: 1 μm. Images
reprinted from Ref. 37, with permission.
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a detrimental process; acidification and crowding upon inges-
tion into transport vesicles appear to provide conditions by
which tau can aggregate. The last panel in Fig. 6(d), shows a
two-color superresolution image of fibrillar species found in
the extracellular medium, after extended periods of K18Tau
incubation of the cells. Intriguingly, the cell expels fibrillar
aggregates that contain both the ingested K18Tau, shown in
red, and endogenous wild-type tau, already present in the
cell, shown in green. The image proves beyond doubt that
the extracellular K18Tau, which aggregates on ingestion into
neuron-like cells, acts as a template, which “seeds” the coaggre-
gation of endogenous, “healthy” tau. This has major pathologi-
cal implications, as the model suggests that ingested tau could
potentially become toxic and lead to the formation of aggrega-
tion nuclei, from which coaggregation of healthy protein species
can proceed and propagate from cell to cell. The study further-
more suggests that the mere presence of tau in the extracellular
space, e.g., following a brain trauma that causes local cell death
and thus release of tau, can have potentially devastating effects;
subsequent ingestion by adjacent, healthy cells triggers its
aggregation and the consecutive recruitment and coaggregation
of endogenous tau, starting a vicious circle, which mimics
the disease cascade that may go on in humans. More generally,
the study complements our other study on Aβ uptake and
aggregation26 in suggesting that vesicular compartmentalization
and acidification may be quite a general principle by which
amyloid aggregation may proceed in cells.
5 Conclusions and Future Outlook
This short review has put in focus recent developments in optical
imaging that permit us to gain information, at the nanoscale,
of the self-assembly process of neurotoxic protein species.
Functional imaging techniques, so-called multiparameter imag-
ing techniques, use spectroscopic signature changes to inform
on the protein aggregation process. On the other hand, optical
superresolution techniques reveal greater spatial detail than has
been hitherto possible.30 In combination, these techniques are
greatly empowering ways to perform research into neurodegen-
erative diseases and to probe their molecular origins. A myriad
of unresolved questions is now open to “illumination” by these
tools, raising hopes to find a cure for these devastating illnesses.
An extremely promising technique for studies of amyloid
growth kinetics to rival dSTORM is total internal reflection fluo-
rescence microscopy with structured illumination microscopy
(TIRF-SIM).37 The technique is capable of providing a spatial
resolution in reconstructed images of <100 nm (see Fig. 7) and
has several advantages over dSTORM in the present context.38 It
provides excellent image contrast and rejects bulk fluorescence
that hampers standard implementations of SIM. Furthermore,
it permits dynamic imaging, with frame rates >10 Hz easily
possible. The method does not require the use of photoswitch-
able fluorophores or special buffers and is thus ideally suited for
kinetic time-lapse imaging, even in live cells. For screening of
small molecule compounds interacting with aggregating pro-
teins and studies of the transmission of toxic species from
cell to cell, this may well prove to be the method of choice in
the future.
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